PuSH - Publication Server of Helmholtz Zentrum München

81 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
61.
Garzorz, N.V.* et al.: Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. J. Invest. Dermatol. 134, S1 (2014)
62.
Garzorz-Stark, N.* et al.: Eczema ≠ eczema: The transcriptional heterogeneity of eczema. Br. J. Dermatol. 170, E19 (2014)
63.
Kretschmer, A. et al.: A common atopy-associated variant in the TH2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding. Allergy 69, 632-642 (2014)
64.
Kretschmer, A. et al.: A common atopy-associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding. Exp. Dermatol. 23, E22 (2014)
65.
Kretschmer, A. et al.: A common atopy-associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding. J. Invest. Dermatol. 134, S55 (2014)
66.
Quaranta, M. et al.: Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Exp. Dermatol. 23, E20 (2014)
67.
Quaranta, M. et al.: Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci. Transl. Med. 6:244ra90 (2014)
68.
Quaranta, M. et al.: Allergic contact dermatitis in psoriasis patients: Typical, delayed, and non-interacting. PLoS ONE 9:e101814 (2014)
69.
Quaranta, M.* et al.: Intraindividual genome expression analysis reveals opposing immune reaction in psoriasis and eczema. Br. J. Dermatol. 171, E135 (2014)
71.
Kiss, E.* ; Eggel, A.* ; Manel, N.* & Eyerich, S.: 2013 ACTERIA prize winners: Early career scientists who will make a difference. Eur. J. Immunol. 43, 1684-1685 (2013)
72.
Pennino, D. et al.: IL-22 suppresses IFN-γ-mediated lung inflammation in asthmatic patients. J. Allergy Clin. Immunol. 131, 562-570 (2013)
73.
Fischer-Stabauer, M.* et al.: Differential in situ expression of IL-17 in skin diseases. Eur. J. Dermatol. 22, 781-784 (2012)
74.
Eyerich, S. et al.: IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur. J. Immunol. 41, 1894-1901 (2011)
75.
Eyerich, S. et al.: Mutual antagonism of T cells causing psoriasis and atopic eczema. N. Engl. J. Med. 365, 231-238 (2011)
76.
Eyerich, S. et al.: Neue Schlüsselzytokine in der Allergologie: IL-17, IL-22. Allergologie 34, 344-349 (2011)
77.
Liu, L.* et al.: Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635-1648 (2011)
78.
Eyerich, K. ; Eyerich, S. ; Hiller, J. ; Behrendt, H. & Traidl-Hoffmann, C.: Chronic mucocutaneous candidiasis, from bench to bedside. Eur. J. Dermatol. 20, 260-265 (2010)
79.
Eyerich, S. ; Eyerich, K. ; Cavani, A.* & Schmidt-Weber, C.B.*: IL-17 and IL-22: Siblings, not twins. Trends Immunol. 31, 354-361 (2010)
80.
Pennino, D.* et al.: IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J. Immunol. 184, 4880-4888 (2010)